Navigation Links
Neuromed Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED-1077
Date:11/20/2008

VANCOUVER, BC and CONSHOHOCKEN, PA, Nov. 20 /PRNewswire/ - Neuromed Pharmaceuticals, a biopharmaceutical company developing new and improved chronic pain drugs, announced today it has completed enrollment in the pivotal Phase 3 chronic low back pain clinical trial of NMED-1077 (OROS(R) Hydromorphone) for the treatment of chronic moderate-to-severe pain in opioid tolerant patients.

"The completion of patient enrollment brings us closer to reaching our goal of providing a highly effective once-daily pain medication for patients with chronic moderate-to-severe pain," said Dr. Christopher Gallen, President and Chief Executive Officer. "If approved, this will be the only long-acting hydromorphone available in the U.S. market with a single dose providing around the clock pain relief for patients."

The design of the Phase 3 trial of NMED-1077 is a randomized withdrawal, placebo-controlled, double-blind trial which is being conducted at multiple centers in the U.S. The study is evaluating the safety and efficacy of NMED-1077 in 269 opioid tolerant patients for the treatment of chronic low back pain. While the FDA indicated in an Approvable Letter that one successful adequate and well-controlled clinical trial will be needed to support approval of OROS(R) Hydromorphone in the U.S., Neuromed is conducting a second pivotal Phase 3 trial for the treatment of osteoarthritic pain. Patient enrollment for this second trial is ongoing.

The pivotal Phase 3 clinical trials of NMED-1077 are being studied under Special Protocol Assessment (SPA) agreements with the U.S. Food and Drug Administration (FDA). A SPA is a procedure by which sponsors and the FDA reach agreement on the design and size of clinical trials intended to form the primary basis to support approval of a New Drug Application.

About NMED-1077

Neuromed acquired from ALZA Corporation the U.S. marketing rights to NMED-1077, an extended release formula
'/>"/>

SOURCE Neuromed Pharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Nfocus Neuromedical Announces Acquisition of StarFire Medical
2. Nfocus Neuromedical Receives CE Mark for the CardioVasc(TM) Stent-Graft and Delivery System
3. Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
4. Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
5. Ashland Completes Acquisition of Hercules
6. Conseco Completes Transfer of Senior Health Insurance Company of Pennsylvania to Independent Trust
7. Hyperion Therapeutics Completes Phase 2 Data Analysis and Schedules End of Phase 2 Meeting With FDA for HPN-100 in the Chronic Treatment of Urea Cycle Disorders
8. Cardium Completes $6.0 Million Financing
9. PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF
10. TomoTherapy Completes Acquisition of Linear Accelerator Manufacturer in China
11. Phyhealth Completes $250,000 Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... BPI Sports , a leading ... Award at this year's GNC Franchise Convention held June ... is "Partner of the Year." This is the third ... 15 months, the other two being the 2011 "Rising ... BPI continues to pave the way for the sports ...
(Date:6/17/2013)... San Antonio, Texas (PRWEB) June 17, 2013 San ... newest location at 511 Dallas St. has just opened up a ... have been asking for a downtown optical shop over the years, ... optical shop brings SA Eye Center one step closer to providing ... addition to better access. The downtown optical shop is the ...
(Date:6/17/2013)... confronting childhood obesity, researchers at the Johns Hopkins ... approaches are important. A systematic review of childhood ... that incorporate schools and focus on both diet ... obesity in children. The results of the study ... , "In measuring the effectiveness of community-based programs ...
(Date:6/17/2013)... 17, 2013 Earlier this year, ... adopted tough standards to strengthen the privacy and ... Insurance Portability and Accountability Act (HIPAA) with the ... of the privacy of their health records and ... information, while also supporting the government’s ability to ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 The ... announce that they are now open in Schertz. ... neurofeedback treatments, counseling and access to educational support ... can be used to help with athletic performance, ... of the center, Cheryl Camarillo, LCSW, works primarily ...
Breaking Medicine News(10 mins):Health News:GNC Awards Another Prestigious Award to BPI Sports - 2012 Partner of the Year 2Health News:San Antonio Eye Center PA Opens New Optical Shop 2Health News:Community-based programs may help prevent childhood obesity 2Health News:Six Tips for Healthcare Providers About the New HIPAA Omnibus Rule 2Health News:Six Tips for Healthcare Providers About the New HIPAA Omnibus Rule 3Health News:Professional Center for Enhanced Performance Opens in Schertz 2
... modality in the treatment of coronary artery ... to bypass clogged arteries and damaged tissue. ... out for two important blood vessel growth factors, fibroblast ... (VEGF), have not yielded sterling outcomes. ...
... According to optometrist Dr. Ana Juricic there is an ... related macular degeneration. Not only that the situation// is ... people. She says that macular degeneration and cataracts ... age group. Dr. Juricic also advices her patients to ...
... On June 14th it was the World Blood Donor Day ... , Canadian Blood Services honored ... Organization (WHO) members, and more than 200 voluntary blood donor organizations, ... blood, plasma, platelets and bone marrow donation. Several clinics were organized ...
... flu with a 31-year-old man from south China's Guangdong Province ... ,The patient, surnamed Jiang, is a migrant worker in Shenzhen ... and has been hospitalised. He is now in critical condition, ... have found Jiang had been to a local market, where ...
... another eating disorder, it's just the name given to ... University of Glamorgan //says that muscle men are suffering ... from anorexia and bulimia. ,"Gym-goers are increasingly ... altered body images," he said. "Sufferers of negative or ...
... in New Zealand report low levels of perceived security ... according to a new survey//. ,The Youth 2000 ... Service and Auckland University, asked 922 Asian students about ... and school. ,Chinese and Indian students made ...
Cached Medicine News:Health News:Growth Factor Aids in Regeneration of Heart Blood Vessel 2Health News:AMD Found To Affect People In Their 50s 2Health News:Indian Students in New Zealand Feel Insecure 2
(Date:6/17/2013)... 2013 The law firm of Rheingold, Valet, Rheingold, ... to be the first suit in New York ... user of two common anti-diabetic drugs, Byetta and Janumet (also ... resident Robert Cataletto , was filed on ... E.D.N.Y. CV 13-3411. Mr. Cataletto received prescriptions from ...
(Date:6/17/2013)... June 17, 2013   Southern Research Institute ... has been selected by its Board of Directors to ... July 8, 2013.   (Photo: http://photos.prnewswire.com/prnh/20130617/DC33167 ... Secrist, III, Ph.D., who served as president and CEO ... his retirement earlier this year after 34 years of ...
(Date:6/17/2013)... AVIV, Israel , June 17, 2013 ... the Board of Governors of the Israel-U.S. Binational Industrial ... million in funding for fourteen new projects between Israeli ... BIRD , the projects will access private sector ... approximately $33 million. The semi-annual meeting was held at ...
Breaking Medicine Technology:Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet 2Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 2Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 2BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 4
... 2011 Time is money, and time that is wasted looking ... A first-of-its-kind mobile and HTML5 app released by Providian Medical ... both time and money. With just a few quick and easy ... the optimum ultrasound machines based on their individual needs. The app ...
... SuccessEHS will sponsor the California Primary Care Association (CPCA) ... statewide leader and recognized voice representing the interests of ... CPCA represents more than 800 not-for-profit community clinics and ... SuccessEHS supports CPCA,s mission of eliminating ...
Cached Medicine Technology:Providian Medical Launches New Tool to Make Finding the Right Ultrasound Machine Easier Than Ever 2SuccessEHS Sponsors California Primary Care Association 2SuccessEHS Sponsors California Primary Care Association 3
Micro-hematocrit tubes available in multiple sizes and additives for a wide range of capillary blood collection....
... VH IVUS technology uses advanced spectral ... of ultrasound images and provide detailed ... patient's atherosclerotic plaques. The colorized VH ... fibrous, fibro-fatty, dense calcium, and necrotic ...
... Innova 2100IQ: See the finest vessels from ... devices. Its all enabled by the Revolution ... deliver excellent image quality and dose efficiency. ... installed worldwide, more physicians rely on these ...
... as Antidiurectic Hormone (ADH), is synthesized in ... flow to the posterior pituitary for storage ... by changes in blood osmolality and also ... blood volume or arterial pressure. Non-osmotic stimuli ...
Medicine Products: